Risk assessments are processes of identifying risks that exist or may appear. Risk assessments define and assess hazards that are likely to cause harm to service users and/or staff. This allows services to comply with CQC regulation 12: Safe Care and treatment. This regulation states “Providers must assess the risks to people’s health and safety during any care or treatment ”, “Providers must make sure that the premises and any equipment used is safe” and “CQC understands that there may be inherent risks in carrying out care and treatment, and we will not consider it to be unsafe if providers can demonstrate that they have taken all reasonable steps to ensure the health and safety of people using their services and to manage risks that may arise during care and treatment.”
This risk assessment is for the use of Alendronic Acid. Alendronic acid is a type of medicine called a bisphosphonate. Bisphosponates are prescribed to help people’s bones stay as strong as possible. Taking alendronic acid can help if someone has, or is at risk of developing osteoporosis.